logo
Select company
Select metric
11.53%Cash to Assets Ratio
VS
Market
60
Sector
27
Industry
14
History
33
$ 2.52Close
$ 2.36 - $ 27 52-Week Range
Ticker Information

Ticker

AIM

Company Name

AIM IMMUNOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

AIM IMMUNOTECH INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIM - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 4.13M$ 476K11.53%
3/31/2025$ 6.25M$ 898K14.37%
12/31/2024$ 8.61M$ 1.7M19.76%
9/30/2024$ 13.59M$ 915K6.73%
6/30/2024$ 15.71M$ 3.55M22.62%
3/31/2024$ 16.19M$ 3.29M20.35%
12/31/2023$ 19.38M$ 5.44M28.06%
9/30/2023$ 27.86M$ 15.26M54.79%
6/30/2023$ 33.62M$ 21.04M62.58%
3/31/2023$ 37.46M$ 23.39M62.45%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AIM IMMUNOTECH INC's latest trailing twelve months (TTM) Cash to Assets stands at 60%.
  • Over the past 5 years, AIM IMMUNOTECH INC's average Cash to Assets has been 45.88%.
  • The median Cash to Assets for AIM IMMUNOTECH INC during this period was 57.42%
  • AIM IMMUNOTECH INC reached its highest Cash to Assets over the past 5 years at 67.71%.
  • The lowest Cash to Assets recorded by AIM IMMUNOTECH INC in the same timeframe 6.73%

AIM IMMUNOTECH INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
SILO : SILO PHARMA INC 65.14%VIVS : VIVOSIM LABS INC 76.79%HCWB : HCW BIOLOGICS INC 8.44%CDIO : CARDIO DIAGNOSTICS HOLDINGS INC 76.75%IBO : IMPACT BIOMEDICAL INC 3.27%PMCB : PHARMACYTE BIOTECH INC 29.21%APVO : APTEVO THERAPEUTICS INC 60.23%ACXP : ACURX PHARMACEUTICALS INC 98.48%PALI : PALISADE BIO INC 81.64%GNPX : GENPREX INC 35.19%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for AIM IMMUNOTECH INC is calculated as follows: CashnEq [ $ 38.5M ] / Assets [ $ 64.16M ]
(=) Cash to Assets [ 60% ]

AIM - Cash to Assets Ratio, Last 5 years

6.73%

Minimum

Sep 30, 2024

67.71%

Maximum

Jun 30, 2022

45.88%

Average

57.42%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%